Karim Lalji, CEO, will participate in panel discussion during BioFuture 2023, Infectious Disease: From Neglect to Respect Made Possible by New Technologies The Company will also present its new class of therapeutic compounds and clinical development programs targeting rare, chronic, and…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.